Anupam Rasayan India Reports Robust Q2 Revenue Growth, Net Profit Surges 86.6%

2 min read     Updated on 17 Oct 2025, 10:17 AM
scanx
Reviewed by
Naman SharmaScanX News Team
Overview

Anupam Rasayan India Ltd reported impressive Q2 FY2025-26 results. Consolidated revenue surged 148.8% to ₹7,313.98 crore. Net profit increased by 86.6% to ₹571.52 crore. EBITDA grew 68.9% to ₹1,358.89 crore. However, EBITDA margin contracted to 18.54% from 27.35%. The company raised ₹3,700 crore through preferential allotment, using ₹2,768.98 crore for loan repayment and corporate purposes. Total assets reached ₹56,498.46 crore, with equity base expanding to ₹31,972.88 crore.

22222041

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Ltd , a leading specialty chemicals company, has reported a strong financial performance for the second quarter of the fiscal year 2025-26. The company's results showcase significant growth in revenue and profitability, despite a contraction in margins.

Revenue Soars

For the quarter ended September 30, 2025, Anupam Rasayan reported a consolidated revenue of ₹7,313.98 crore, marking a substantial increase of 148.8% compared to ₹2,939.62 crore in the same quarter of the previous year. This impressive top-line growth underscores the company's expanding market presence and strong demand for its specialty chemical products.

Profitability Surge

The company's bottom line saw a significant improvement:

  • Net profit for Q2 FY2025-26 stood at ₹571.52 crore, up by 86.6% from ₹306.23 crore in Q2 FY2024-25.
  • On a half-yearly basis, the net profit reached ₹1,056.10 crore, showing a remarkable growth of 146.6% compared to ₹428.34 crore in the corresponding period of the previous year.

EBITDA Performance

Anupam Rasayan's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the quarter increased to ₹1,358.89 crore, up from ₹804.05 crore in the same quarter last year, representing a growth of 68.9%.

Margin Pressure

Despite the strong revenue and profit growth, the company experienced some pressure on its margins:

  • EBITDA margin for Q2 FY2025-26 contracted to 18.54% from 27.35% in Q2 FY2024-25.
  • This margin contraction suggests that while the company has significantly expanded its operations, it may be facing some cost pressures or changes in product mix affecting overall profitability ratios.

Financial Position

As of September 30, 2025, Anupam Rasayan's balance sheet reflects a solid financial position:

  • Total assets stood at ₹56,498.46 crore, up from ₹52,688.84 crore as of March 31, 2025.
  • The company's equity base expanded to ₹31,972.88 crore, compared to ₹28,503.13 crore at the end of the previous fiscal year.

Capital Allocation

During the quarter, Anupam Rasayan made strategic moves to strengthen its capital structure:

  • The company allotted 39,14,886 fully paid-up equity shares at an issue price of ₹945.11 per share through a preferential allotment.
  • This move raised approximately ₹3,700 crore, of which ₹2,768.98 crore has been utilized for loan repayment and general corporate purposes.

Looking Ahead

As Anupam Rasayan continues to expand its operations and capitalize on the growing demand for specialty chemicals, managing costs and improving operational efficiency will be key focus areas to enhance profitability margins in the coming quarters.

The company's robust financial performance, coupled with its strategic capital raising, positions it well for future growth in the dynamic specialty chemicals sector.

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
-5.46%-4.77%-3.63%+32.64%+47.11%+102.11%
Anupam Rasayan
View in Depthredirect
like16
dislike

Anupam Rasayan India Appoints Chemical Industry Veteran Milind Madan Talathi as Independent Director

1 min read     Updated on 25 Sept 2025, 08:24 PM
scanx
Reviewed by
Naman SharmaScanX News Team
Overview

Anupam Rasayan India Limited has appointed Mr. Milind Madan Talathi as an Additional Director (Non-Executive Independent) for a three-year term from September 25, 2025, to September 24, 2028, subject to shareholder approval. Talathi brings four decades of experience in chemical manufacturing, with expertise in operations, EHS, HR, and supply chain management. He has held leadership positions at companies like Rallis India, Century Enka, and ELANTAS Beck India. Talathi will also join the company's Risk Management Committee.

20357662

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited , a leading specialty chemicals company, has announced the appointment of Mr. Milind Madan Talathi as an Additional Director, categorized as Non-Executive Independent Director, for a three-year term. This strategic move, approved by the company's Board of Directors, aims to bring extensive industry experience to its leadership team.

Appointment Details

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, approved Talathi's appointment for a term spanning from September 25, 2025, to September 24, 2028. This appointment is subject to shareholder approval at the upcoming general meeting.

Expertise and Background

Mr. Talathi brings a wealth of experience to Anupam Rasayan, with a career spanning around four decades in the chemical manufacturing sector. His expertise covers a wide range of areas, including:

  • Operations management
  • Environmental Health and Safety (EHS)
  • Human Resources and Industrial Relations
  • Innovation and Supply Chain Management
  • Regulatory liaison

Talathi's educational background includes:

  • A degree in Chemical Engineering from UDCT Mumbai
  • A Management degree from Pune University
  • Additional courses from prestigious institutions like IIM-A and TMTC

Professional Journey

Throughout his illustrious career, Mr. Talathi has held several leadership positions in renowned companies:

  • Started his career with Tata Group's Rallis India Ltd. in Chandigarh
  • Served as President (Operations) at Century Enka Ltd. for their Pune & Mahad sites
  • Held the position of COO at Gujarat Fluorochemicals in Dahej
  • Appointed as Whole Time Director at ELANTAS Beck India Ltd., part of the ALTANA GmbH Group

Additional Responsibilities

In addition to his role as an Independent Director, Talathi will also join Anupam Rasayan's Risk Management Committee, effective from his appointment date.

Industry Involvement

Mr. Talathi is actively involved in various industry and community roles:

  • Chairman of the Chemical Sector Vertical at MCCIA
  • Member of the Start-up Advisory Council at MIT-TBI
  • Mentor to several entrepreneurs
  • Engaged with the UDCT Alumni Association and the Indian Institute of Chemical Engineers
  • Associated with Lions Club of Pune, Sahakarnagar

Compliance and Independence

The company has confirmed that Mr. Talathi meets the independence criteria as prescribed under the Companies Act, 2013 and SEBI Listing Regulations. Furthermore, he is not related to any existing directors of Anupam Rasayan India Limited.

This appointment underscores Anupam Rasayan's commitment to strengthening its board with experienced professionals, potentially enhancing its strategic decision-making capabilities in the competitive specialty chemicals market.

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
-5.46%-4.77%-3.63%+32.64%+47.11%+102.11%
Anupam Rasayan
View in Depthredirect
like20
dislike
More News on Anupam Rasayan
Explore Other Articles
1,064.70
-61.50
(-5.46%)